Skip to main content
placeholder image

Medicinal Cannabis and the Tyranny of Distance: Policy Reform Required for Optimizing Patient and Health System Net Benefit in Australia

Journal Article


Abstract


  • In the evolution of any novel concept, there is a spectrum in

    the rate at which individuals adopt a new idea, a diffusion of

    innovation stretching from innovators to laggards [

    1]. Such a

    distribution is emerging globally in the rapidly evolving field

    of medicinal cannabis (MC). Countries such as Israel, the

    Netherlands and, more recently, Canada could be regarded as

    innovators [

    2, 3]. They have taken pragmatic health system-

    based responses to the needs of patients, facilitating access to

    those with highest expected net clinical benefit while con-

    ducting trials and studies in parallel. Even the USA, with its

    patchwork quilt of innovation and lack of federal oversight,

    is developing insights into what works for their patient

    populations, and what doesn’t [

    4].

Publication Date


  • 2018

Citation


  • D. Caldicott, J. Sinclair, L. Sheridan & S. Eckermann, "Medicinal Cannabis and the Tyranny of Distance: Policy Reform Required for Optimizing Patient and Health System Net Benefit in Australia", Applied Health Economics and Health Policy 16 2 (2018) 153-156.

Scopus Eid


  • 2-s2.0-85042384873

Number Of Pages


  • 3

Start Page


  • 153

End Page


  • 156

Volume


  • 16

Issue


  • 2

Place Of Publication


  • New Zealand

Abstract


  • In the evolution of any novel concept, there is a spectrum in

    the rate at which individuals adopt a new idea, a diffusion of

    innovation stretching from innovators to laggards [

    1]. Such a

    distribution is emerging globally in the rapidly evolving field

    of medicinal cannabis (MC). Countries such as Israel, the

    Netherlands and, more recently, Canada could be regarded as

    innovators [

    2, 3]. They have taken pragmatic health system-

    based responses to the needs of patients, facilitating access to

    those with highest expected net clinical benefit while con-

    ducting trials and studies in parallel. Even the USA, with its

    patchwork quilt of innovation and lack of federal oversight,

    is developing insights into what works for their patient

    populations, and what doesn’t [

    4].

Publication Date


  • 2018

Citation


  • D. Caldicott, J. Sinclair, L. Sheridan & S. Eckermann, "Medicinal Cannabis and the Tyranny of Distance: Policy Reform Required for Optimizing Patient and Health System Net Benefit in Australia", Applied Health Economics and Health Policy 16 2 (2018) 153-156.

Scopus Eid


  • 2-s2.0-85042384873

Number Of Pages


  • 3

Start Page


  • 153

End Page


  • 156

Volume


  • 16

Issue


  • 2

Place Of Publication


  • New Zealand